Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Pharmaceuticals (Basel, Switzerland)|June 28, 2023
Current Status and Challenges of Oncolytic Virotherapy for the Treatment of GlioblastomaMason J Webb, Ugur Sener, Richard G Vile
Journal of Immunotherapy and Precision Oncology|May 9, 2024
Immune Checkpoint Inhibitors and Glioblastoma: A Review on Current State and Future DirectionsMerve Hazal Ser, Mason J Webb, Ugur Sener, et al.
Pharmaceutics|April 28, 2023
The Current Status, Challenges, and Future Potential of Therapeutic Vaccination in GlioblastomaBryan J Neth, Mason J Webb, Ian F Parney, et al.
Current Oncology Reports|March 15, 2024
Cerebrospinal Fluid Liquid Biopsies in the Evaluation of Adult GliomasAllison R Valerius, Mason J Webb, Nouran Hammad, et al.
Journal of Neuro-Oncology|July 14, 2023
Belzutifan in adults with VHL-associated central nervous system hemangioblastoma: a single-center experienceBryan J Neth, Mason J Webb, Jessica White, et al.
CNS Oncology|July 26, 2023
Proton craniospinal irradiation with bevacizumab and pembrolizumab for leptomeningeal disease: a case reportMason J Webb, William G Breen, Nadia N Laack, et al.
Medicine|July 5, 2024
A case series of osseous metastases in patients with glioblastomaLauren Michelle Webb, Mason J Webb, Jian L Campian, et al.
Molecular Therapy Oncolytics|June 14, 2023
Trap and ambush therapy using sequential primary and tumor escape-selective oncolytic virusesMason J Webb, Timothy Kottke, Benjamin L Kendall, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 3, 2025
The progressively exhausted T cell response to a poorly immunogenic model of HCC can be partially rescued by immune checkpoint blockade and is heavily suppressed by T cell responses to oncolytic virotherapyThanich Sangsuwannukul, Benjamin Kendall, Jason Tonne, et al.
Nature Communications|June 27, 2024
Expression of tumor antigens within an oncolytic virus enhances the anti-tumor T cell responseMason J Webb, Thanich Sangsuwannukul, Jacob van Vloten, et al.
Pageof 1